Tarsus Pharmaceuticals, Inc. (TARS)

Tarsus Pharmaceuticals Revenue

Tarsus Pharmaceuticals had revenue of $173.91M in the quarter ending June 30, 2026, with 69.41% growth. This brings the company's revenue in the last twelve months to $606.33M, up 105.17% year-over-year. In the year 2025, Tarsus Pharmaceuticals had annual revenue of $451.36M with 146.71% growth.

• Revenue (ttm): $606.33M
• Revenue Growth: +105.17%
• P/S Ratio: 5.01
• Revenue / Employee: $1,638,732
• Employees: 370
• Market Cap: 3.04B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	451.36M	268.41M	146.71%
Dec 31, 2024	182.95M	165.51M	948.62%
Dec 31, 2023	17.45M	-8.37M	-32.42%
Dec 31, 2022	25.82M	-31.21M	-54.73%
Dec 31, 2021	57.03M	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 12, 2026

Data Sources Report a data error